The essence of senescence - PubMed (original) (raw)

Review

The essence of senescence

Thomas Kuilman et al. Genes Dev. 2010.

Abstract

Almost half a century after the first reports describing the limited replicative potential of primary cells in culture, there is now overwhelming evidence for the existence of "cellular senescence" in vivo. It is being recognized as a critical feature of mammalian cells to suppress tumorigenesis, acting alongside cell death programs. Here, we review the various features of cellular senescence and discuss their contribution to tumor suppression. Additionally, we highlight the power and limitations of the biomarkers currently used to identify senescent cells in vitro and in vivo.

PubMed Disclaimer

Figures

Figure 1.

The essence of senescence: biomarkers in vivo. Several markers of cellular senescence have been identified in early neoplastic lesions in both mice and humans. Representative examples are shown in the various columns, with the type of genetic lesions or other types of stress (stress categories, color-coded) that instigate senescence at the very top and very bottom, and from thereon inward: the tissue types, specific stress signals, biomarkers, and symbols legends, respectively. For instance, in BRAF mutant nevi, the stress category is oncogene activation (blue), the tissue type is nevus, the specific stress signal is BRAF, and the biomarkers reported are cell cycle arrest, increase in SA-β-GAL activity, and tumor suppressor activation. (CTX) Cyclophosphamide; (βCAT) β-catenin; (GL) gland; (N.D.) not determined.

Similar articles

• Aging and cancer: the double-edged sword of replicative senescence.
  Campisi J. Campisi J. J Am Geriatr Soc. 1997 Apr;45(4):482-8. doi: 10.1111/j.1532-5415.1997.tb05175.x. J Am Geriatr Soc. 1997. PMID: 9100719 Review.
• Replicative senescence and oxidant-induced premature senescence. Beyond the control of cell cycle checkpoints.
  Chen QM. Chen QM. Ann N Y Acad Sci. 2000 Jun;908:111-25. doi: 10.1111/j.1749-6632.2000.tb06640.x. Ann N Y Acad Sci. 2000. PMID: 10911952 Review.
• Cellular senescence in cancer.
  Kim YH, Park TJ. Kim YH, et al. BMB Rep. 2019 Jan;52(1):42-46. doi: 10.5483/BMBRep.2019.52.1.295. BMB Rep. 2019. PMID: 30526772 Free PMC article. Review.
• Cellular senescence in cardiac diseases.
  Shimizu I, Minamino T. Shimizu I, et al. J Cardiol. 2019 Oct;74(4):313-319. doi: 10.1016/j.jjcc.2019.05.002. Epub 2019 Jun 12. J Cardiol. 2019. PMID: 31202488 Review.
• Replicative senescence and senescence-like state induced in cancer-derived cells.
  Hwang ES. Hwang ES. Mech Ageing Dev. 2002 Nov;123(12):1681-94. doi: 10.1016/s0047-6374(02)00102-1. Mech Ageing Dev. 2002. PMID: 12470905 Review.

Cited by

• Forging a signature of in vivo senescence.
  Sharpless NE, Sherr CJ. Sharpless NE, et al. Nat Rev Cancer. 2015 Jul;15(7):397-408. doi: 10.1038/nrc3960. Nat Rev Cancer. 2015. PMID: 26105537 Review.
• YBX1 Regulates Satellite II RNA Loading into Small Extracellular Vesicles and Promotes the Senescent Phenotype.
  Chiba M, Miyata K, Okawa H, Tanaka Y, Ueda K, Seimiya H, Takahashi A. Chiba M, et al. Int J Mol Sci. 2023 Nov 16;24(22):16399. doi: 10.3390/ijms242216399. Int J Mol Sci. 2023. PMID: 38003589 Free PMC article.
• Senescent cells talk frankly with their neighbors.
  Biran A, Krizhanovsky V. Biran A, et al. Cell Cycle. 2015;14(14):2181-2. doi: 10.1080/15384101.2015.1056608. Epub 2015 Jun 1. Cell Cycle. 2015. PMID: 26030140 Free PMC article. No abstract available.
• A high-content cellular senescence screen identifies candidate tumor suppressors, including EPHA3.
  Lahtela J, Corson LB, Hemmes A, Brauer MJ, Koopal S, Lee J, Hunsaker TL, Jackson PK, Verschuren EW. Lahtela J, et al. Cell Cycle. 2013 Feb 15;12(4):625-34. doi: 10.4161/cc.23515. Epub 2013 Jan 16. Cell Cycle. 2013. PMID: 23324396 Free PMC article.
• Cellular senescence and metabolic reprogramming: Unraveling the intricate crosstalk in the immunosuppressive tumor microenvironment.
  Zhang F, Guo J, Yu S, Zheng Y, Duan M, Zhao L, Wang Y, Yang Z, Jiang X. Zhang F, et al. Cancer Commun (Lond). 2024 Sep;44(9):929-966. doi: 10.1002/cac2.12591. Epub 2024 Jul 12. Cancer Commun (Lond). 2024. PMID: 38997794 Free PMC article. Review.

References

1. 1. Acosta JC, O'Loghlen A, Banito A, Guijarro MV, Augert A, Raguz S, Fumagalli M, Da Costa M, Brown C, Popov N, et al. 2008. Chemokine signaling via the CXCR2 receptor reinforces senescence. Cell 133: 1006–1018 - PubMed
2. 1. Adams PD 2007. Remodeling of chromatin structure in senescent cells and its potential impact on tumor suppression and aging. Gene 397: 84–93 - PMC - PubMed
3. 1. Adams PD 2009. Healing and hurting: Molecular mechanisms, functions, and pathologies of cellular senescence. Mol Cell 36: 2–14 - PubMed
4. 1. Agger K, Cloos PA, Rudkjaer L, Williams K, Andersen G, Christensen J, Helin K 2009. The H3K27me3 demethylase JMJD3 contributes to the activation of the INK4A–ARF locus in response to oncogene- and stress-induced senescence. Genes Dev 23: 1171–1176 - PMC - PubMed
5. 1. Alcorta DA, Xiong Y, Phelps D, Hannon G, Beach D, Barrett JC 1996. Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts. Proc Natl Acad Sci 93: 13742–13747 - PMC - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • HighWire
  • PubMed Central

• Other Literature Sources

  • The Lens - Patent Citations Database